Fig. 3From: Seven-year outcomes of combined treatment of anti-vascular endothelial growth factor with photodynamic therapy for polypoidal choroidal vasculopathy; according to polypoidal lesion regressionChanges in anatomical factors after the combination of photodynamic therapy (PDT) with intravitreal anti-vascular endothelial growth factor (Anti-VEGF) injections for polypoidal choroidal vasculopathy. (a) Changes in central foveal thickness (CFT). (b) Changes in pigment epithelial detachment (PED) volumeBack to article page